Recruiting Primary Biliary Cholangitis Studies in Pasadena
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
To Evaluate the Effect of Seladelpar on Clinical Outcomes in Patients with Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis....
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis
Open-Label Extension Study of Saroglitazar Magnesium in Participants With Primary Biliary Cholangitis...
About Primary Biliary Cholangitis Clinical Trials in Pasadena
Primary biliary cholangitis (PBC) is a chronic autoimmune liver disease in which the bile ducts in the liver are slowly destroyed. This leads to bile buildup, liver damage, and potentially cirrhosis. Treatment includes ursodeoxycholic acid and obeticholic acid.
There are currently 2 primary biliary cholangitis clinical trials recruiting participants in Pasadena, MARYLAND. These studies are seeking a combined 468 participants. Research is being sponsored by Gilead Sciences, Zydus Therapeutics Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Primary Biliary Cholangitis Clinical Trials in Pasadena — FAQ
Are there primary biliary cholangitis clinical trials in Pasadena?
Yes, there are 2 primary biliary cholangitis clinical trials currently recruiting in Pasadena, MARYLAND. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Pasadena?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Pasadena research site will contact you about next steps.
Are clinical trials in Pasadena free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Pasadena studies also compensate for your time and travel.
What primary biliary cholangitis treatments are being tested?
The 2 active trials in Pasadena are testing new therapies including novel drugs, biologics, and treatment approaches for primary biliary cholangitis.
Data updated March 2, 2026 from ClinicalTrials.gov